What's a Normal Sperm Count and What's Borderline

You have a number on a lab sheet, 18 million per mL, 35 percent motility, 3 percent morphology, and an internet that is telling you both that it is fine and that it is alarming. You want to know what the actual reference value is, where your number sits relative to it, and what borderline means for your next decision.

The WHO 2021 (6th edition) reference values are 5th-percentile thresholds derived from men who fathered a pregnancy within 12 months.^{1 2} They describe the lower edge of the fertile range, not a cutoff between "fertile" and "infertile." Reading them as pass/fail is the most common misinterpretation of a semen analysis. If you came here from a wider search on fertility blood tests normal what next, covering everything from day-3 FSH to AMH to the male semen analysis, the principle is the same on both sides. A single result describes a sample, and the right next step depends on the pattern, not the verdict.

Where do the sperm reference values come from?

The WHO 2010 (5th edition) manual was the first to shift away from "normal range" language toward 5th-percentile lower reference limits, drawn from a population of men whose partners had conceived within 12 months.³ The WHO 2021 (6th edition) retained the same statistical framework, refined the methodology, and used a more globally diverse reference population.^{1 2}

A value at the 5th-percentile means 95 percent of recently fertile men exceeded it. It does not mean 95 percent of men below it are infertile. That difference, between describing the lower edge of fertile and defining the boundary of infertile, is what trips couples up most when they first read a report.

A second piece worth knowing: older lab reports still cite WHO 1999 or WHO 2010 thresholds. Check the edition footnoted on your report. The numbers shifted, especially for motility and concentration, between editions.

What are the WHO 2021 sperm reference values?

The reference table for the lower reference limits in WHO 2021:

Parameter	WHO 2021 5th-percentile lower limit
Semen volume	1.4 mL
Sperm concentration	16 million/mL
Total sperm number	39 million per ejaculate
Total motility (progressive + non-progressive)	42%
Progressive motility	30%
Sperm vitality	54% live
Sperm morphology (strict Kruger criteria)	≥ 4% normal forms
pH	≥ 7.2
Leukocytes	< 1 million/mL

A few practical reading notes:

• Read total sperm number (concentration multiplied by volume) alongside concentration. A low-volume sample with a high concentration can still have a normal total number.
• Anti-sperm antibodies (MAR or immunobead test) are reported as the percentage of motile sperm with adherent particles; less than 50 percent is broadly the reference, with higher figures needing clinical correlation.
• These thresholds assume the sample was collected with 2 to 7 days of abstinence and analysed within 1 hour, per WHO methodology.

What does a normal sperm count mean for next steps?

When all parameters sit at or above the lower reference limits, the report is labelled normozoospermia.^{1 5} Natural conception is likely if the female workup is also normal. A normozoospermic result paired with persistent unexplained infertility is still consistent with subtle sperm dysfunction; in that scenario, sperm DNA fragmentation testing becomes a reasonable next step per AUA/ASRM 2021.⁴

The two-direction caveat: normozoospermia does not guarantee fertility, and any result below a cutoff does not preclude conception. The reference values describe statistical patterns in a fertile population, not individual outcomes.

What does a borderline sperm count look like?

The reports that prompt the most worry are the ones with one or two values sitting just under a cutoff. The clinical reading is usually less dramatic than the spreadsheet suggests.

• A concentration of 10 to 16 million per mL prompts a repeat after 4 or more weeks, a lifestyle review, and a hormone screen if the second result confirms the pattern.
• A progressive motility of 25 to 30 percent prompts a check on sample handling (was the sample analysed within an hour, kept at body temperature, collected in the right container?), an abstinence-window review, and a repeat.
• A morphology of 1 to 4 percent by strict criteria, when it is the only abnormal parameter, is typically watched and repeated rather than treated.
• A single borderline value is not a diagnosis. Patterns matter.

The watch-and-repeat instinct is in the guidelines for a reason: spermatogenesis is approximately a 74-day cycle, and a single sample reflects the whole 3-month window leading up to collection.⁴

What do the sperm analysis patterns suggest?

Patterns are more informative than any single number. The named patterns to know:

• Oligozoospermia: concentration below 16 million per mL. Causes include endocrine derangement, varicocele, heat exposure, illness in the prior 3 months, and drugs (testosterone, opioids, finasteride, cannabis at heavy frequency).
• Asthenozoospermia: progressive motility below 30 percent. Causes include heat exposure, oxidative stress, infection, anti-sperm antibodies, and sample-handling errors.
• Teratozoospermia: morphology below 4 percent by strict criteria. The most subjective parameter; an isolated finding is rarely a treatment driver.
• OAT syndrome: oligo-, astheno-, and teratozoospermia together. Needs a urology workup, hormone panel, and scrotal ultrasound.
• Azoospermia: no sperm seen. A separate pathway entirely, with obstructive versus non-obstructive distinction and karyotype plus Y-microdeletion testing.
• Cryptozoospermia: sperm visible only after centrifugation of the pellet. Sits between OAT and azoospermia; this is specialist territory.

I look at the pattern label first, then at the severity within each component.

Which low numbers often improve on a repeat test?

A surprising number of "abnormal" first analyses come back normal on the second one. The patterns I see drive transient suppression include:

1. Recent viral illness or fever in the previous 90 days. Spermatogenesis takes roughly 74 days, so a fever six weeks before collection is still inside the sample window.
2. New medication in the prior 3 months: SSRIs, opioids, finasteride, and any form of exogenous testosterone are the common culprits.
3. Heat exposure patterns: daily hot tubs, sauna routines, occupational heat exposure, laptop-on-lap routines.
4. Heavy alcohol or cannabis use in the prior 3 months.
5. Abstinence window outside the 2-to-7-day range. Too short can drop concentration; too long can drop motility.

This is why a repeat after at least 4 weeks (often 8 to 12 weeks to capture a full spermatogenesis cycle) is the recommended next step before any diagnosis is made.

When does a borderline result need urology?

There are thresholds where the right next move is not another repeat but a urology referral.

• Persistent oligospermia below 5 million per mL on two analyses needs urology, hormone panel, and genetic workup.⁵
• Total motility below 40 percent with a normal concentration on two analyses needs urology.
• Any azoospermic result needs urology; do not repeat indefinitely waiting for a different number.
• History of cryptorchidism, mumps orchitis, chemotherapy, radiation, or prior testicular surgery earns urology involvement from the start.
• A couple with a failed IUI cycle and borderline parameters is a reasonable point to consider DNA fragmentation testing per AUA/ASRM.⁴

These are not rules to memorise but heuristics for when a repeat semen analysis is no longer the most useful next step.

How do you talk about the numbers as a couple?

A practical note on conversation, because the numbers tend to land emotionally and people do not always know what to do with that.

The analysis describes a sample. It does not describe a person. The partner being evaluated is not their concentration figure, and the report is not a verdict on their body. Framing numbers as data points, not as judgments, tends to help. The 74-day spermatogenesis cycle also helps the conversation about pace: lifestyle changes made this week show up in a result three months from now, so the patience between samples is not denial, it is biology.

Repeat-testing decisions are joint decisions. The partner being evaluated may need time before another collection, and that pace deserves respect. Setting a date a few weeks out, rather than pressuring immediate repetition, often gets the workup done more reliably.

What's next

• For parameter-by-parameter detail on what each number means: how to read a semen analysis
• For the full workup framework and how this fits: the male fertility workup overview
• For DNA-level testing when the pattern needs more: sperm DNA fragmentation testing: when and why
• For the 3-month improvement window: preparing your body
• If results are normal and you are still not conceiving, review the female-side workup and the medicated cycles hub

Sources

1. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen, 6th edition. Geneva: WHO Press; 2021. https://www.who.int/publications/i/item/9789240030787
2. Björndahl L, Kirkman Brown J, on behalf of the Editorial Board of the WHO Laboratory Manual. The sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: ensuring quality and standardization in basic examination of human ejaculates. Fertility and Sterility 2022;117(2):246-251. https://doi.org/10.1016/j.fertnstert.2021.12.012
3. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HWG, Behre HM, et al. World Health Organization reference values for human semen characteristics. Human Reproduction Update 2010;16(3):231-245. https://doi.org/10.1093/humupd/dmp048
4. Schlegel PN, Sigman M, Collura B, De Jonge CJ, Eisenberg ML, Lamb DJ, et al. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline Part I and II. Fertility and Sterility 2021;115(1):54-69. https://doi.org/10.1016/j.fertnstert.2020.11.015
5. Boitrelle F, Shah R, Saleh R, Henkel R, Kandil H, Chung E, et al. The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis. Life 2021;11(12):1368. https://doi.org/10.3390/life11121368